Esprit Holdings Limited announced that the following resignations of Directors of the Company: the resignation of Dr. Raymond OR Ching Fai as a Non-executive Director of the Company and Non-executive Chairman of the Board will take effect from 1 January 2021; the resignation of Mr. Carmelo LEE Ka Sze as an Independent Non-executive Director of the Company will take effect from 1 January 2021; and the resignation of Ms. Sandrine Suzanne Eleonore Agar ZERBIB as an Independent Non-executive Director of the Company has taken effect from 24 December 2020. Following the resignation of Dr. OR as a Non-executive Chairman of the Board effective on 1 January 2021, Ms. CHIU Christin Su Yi will be appointed as Acting Executive Chairman of the Board with effect from 1 January 2021. The Board also announced that the following appointments have taken effect from 24 December 2020: the appointment of Mr. DALEY Mark David as an Executive Director and the President; the appointment of Dr. WAN Yung Ting as an Executive Director and the Chief Product Development Officer of the Company; and the appointment of Mr. William Nicholas GILES as an Independent Non-executive Director of the Company. The Board announced the following changes in the composition of Board committees: the resignation of Ms. ZERBIB as Chairman of the Remuneration Committee and members of the Audit Committee and the Risk Management Committee of the Board with effect from 24 December 2020; the appointment of Mr. GILES: (a) as Chairman of the Remuneration Committee and a member of the Audit Committee of the Board with effect from 24 December 2020 and (b) as Chairman of the Risk Management Committee and a member of the Nomination Committee of the Board with effect from 1 January 2021; the appointment of Mr. CHUNG Kwok Pan as a member of the Risk Management Committee of the Board with effect from 24 December 2020; the resignation of Dr. OR as Chairman of the Nomination Committee and a member of the General Committee of the Board with effect from 1 January 2021; the resignation of Mr. LEE as Chairman of the Risk Management Committee, members of the Nomination Committee and the Remuneration Committee of the Board with effect from 1 January 2021; the resignation of Ms. CHIU as a member of the Risk Management Committee of the Board and the appointment of Ms. CHIU as Chairman of the Nomination Committee of the Board with effect from 1 January 2021; the appointment of Dr. WAN as members of the Risk Management Committee and the General Committee of the Board with effect from 1 January 2021. The Board announced the following change of authorised representative of the Company with effect from 1 January 2021: the resignation of Dr. OR as the authorised representative of the Company; and the appointment of Ms. CHIU as the authorised representative of the Company.